Vitamin K-dependent protein activity and incident ischemic cardiovascular disease: The multi-ethnic study of atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 5, 2016, Pages 1037-1042

  Danziger, John ^a   Young, Rebekah L ^b   Shea, M Kyla ^c   Tracy, Russell P ^d   Ix, Joachim H ^e   Jenny, Nancy S ^d   Mukamal, Kenneth J ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c TUFTS UNIVERSITY   (United States)

^d UNIVERSITY OF VERMONT   (United States)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

cardiovascular diseases; prothrombin; risk factors; Vitamin K

Indexed keywords

C REACTIVE PROTEIN; DECARBOXYPROTHROMBIN; PHYTOMENADIONE; UNCLASSIFIED DRUG; VITAMIN K DEPENDENT PROTEIN; VITAMIN K GROUP; BIOLOGICAL MARKER; PROTEIN PRECURSOR; PROTHROMBIN;

ADULT; ARTERIAL STIFFNESS; ARTICLE; BLOOD CLOTTING; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONCENTRATION (PARAMETERS); DIABETES MELLITUS; DIETARY INTAKE; FATALITY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MILD RENAL IMPAIRMENT; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; RISK ASSESSMENT; AGED; ATHEROSCLEROSIS; BLOOD; CLINICAL TRIAL; EPIDEMIOLOGY; ETHNOLOGY; INCIDENCE; KAPLAN MEIER METHOD; MORTALITY; MULTICENTER STUDY; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; STROKE; TIME FACTOR; UNITED STATES; VERY ELDERLY; VITAMIN K DEFICIENCY;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BIOMARKERS; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; PROTHROMBIN; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; UNITED STATES; VITAMIN K; VITAMIN K DEFICIENCY;

EID: 84962108512     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.116.307273     Document Type: Article

References (45)

1. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G, Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997 386 78 81
2. Schurgers LJ, Spronk HM, Skepper JN, Hackeng TM, Shanahan CM, Vermeer C, Weissberg PL, Proudfoot D, Post-Translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J Thromb Haemost 2007 5 2503 2511. doi: 10.1111/j.1538-7836.2007.02758.x
3. Schneider C, King RM, Philipson L, Genes specifically expressed at growth arrest of mammalian cells. Cell 1988 54 787 793
4. Coutu DL, Wu JH, Monette A, Rivard GE, Blostein MD, Galipeau J, Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells. J Biol Chem 2008 283 17991 18001. doi: 10.1074/jbc.M708029200
5. Stansfield WE, Andersen NM, Tang RH, Selzman CH, Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart. Ann Thorac Surg 2009 88 1916 1921. doi: 10.1016/j.athoracsur.2009.07.038
6. Hakuno D, Kimura N, Yoshioka M, Mukai M, Kimura T, Okada Y, Yozu R, Shukunami C, Hiraki Y, Kudo A, Ogawa S, Fukuda K, Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents. J Clin Invest 2010 120 2292 2306. doi: 10.1172/JCI40973
7. Shea MK, Holden RM, Vitamin K status and vascular calcification: evidence from observational and clinical studies. Adv Nutr 2012 3 158 165. doi: 10.3945/an.111.001644
8. Price PA, Faus SA, Williamson MK, Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998 18 1400 1407
9. Price PA, Faus SA, Williamson MK, Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler Thromb Vasc Biol 2000 20 317 327
10. Jouni H, Rodeheffer RJ, Kullo IJ, Increased serum N-Terminal pro-B-Type natriuretic peptide levels in patients with medial arterial calcification and poorly compressible leg arteries. Arterioscler Thromb Vasc Biol 2011 31 197 202. doi: 10.1161/ATVBAHA.110.216770
11. Niskanen L, Siitonen O, Suhonen M, Uusitupa MI, Medial artery calcification predicts cardiovascular mortality in patients with NIDDM. Diabetes Care 1994 17 1252 1256
12. London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H, Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003 18 1731 1740
13. Schurgers LJ, Uitto J, Reutelingsperger CP, Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med 2013 19 217 226. doi: 10.1016/j.molmed.2012.12.008
14. Schurgers LJ, Barreto DV, Barreto FC, Liabeuf S, Renard C, Magdeleyns EJ, Vermeer C, Choukroun G, Massy ZA, The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin J Am Soc Nephrol 2010 5 568 575. doi: 10.2215/CJN.07081009
15. Rennenberg RJ, de Leeuw PW, Kessels AG, Schurgers LJ, Vermeer C, van Engelshoven JM, Kemerink GJ, Kroon AA, Calcium scores and matrix Gla protein levels: association with vitamin K status. Eur J Clin Invest 2010 40 344 349. doi: 10.1111/j.1365-2362.2010.02275.x
16. Dalmeijer GW, van der Schouw YT, Vermeer C, Magdeleyns EJ, Schurgers LJ, Beulens JW, Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women. J Nutr Biochem 2013 24 624 628. doi: 10.1016/j.jnutbio.2012.02.012
17. Delanaye P, Krzesinski JM, Warling X, Moonen M, Smelten N, Médart L, Pottel H, Cavalier E, Dephosphorylated-uncarboxylated matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients. BMC Nephrol 2014 15 145. doi: 10.1186/1471-2369-15-145
18. Boxma PY, van den Berg E, Geleijnse JM, Laverman GD, Schurgers LJ, Vermeer C, Kema IP, Muskiet FA, Navis G, Bakker SJ, de Borst MH, Vitamin k intake and plasma desphospho-uncarboxylated matrix Gla-protein levels in kidney transplant recipients. PLoS One 2012 7 e47991. doi: 10.1371/journal.pone.0047991
19. Schurgers LJ, Spronk HM, Soute BA, Schiffers PM, DeMey JG, Vermeer C, Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 2007 109 2823 2831. doi: 10.1182/blood-2006-07-035345
20. Shea MK, O'Donnell CJ, Hoffmann U, Dallal GE, Dawson-Hughes B, Ordovas JM, Price PA, Williamson MK, Booth SL, Vitamin K supplementation and progression of coronary artery calcium in older men and women. Am J Clin Nutr 2009 89 1799 1807. doi: 10.3945/ajcn.2008.27338
21. Braam LA, Hoeks AP, Brouns F, Hamulyák K, Gerichhausen MJ, Vermeer C, Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study. Thromb Haemost 2004 91 373 380. doi: 10.1160/TH03-07-0423
22. Maas AH, van der Schouw YT, Beijerinck D, Deurenberg JJ, Mali WP, Grobbee DE, van der Graaf Y, Vitamin K intake and calcifications in breast arteries. Maturitas 2007 56 273 279. doi: 10.1016/j.maturitas.2006.09.001
23. Villines TC, Hatzigeorgiou C, Feuerstein IM, O'Malley PG, Taylor AJ, Vitamin K1 intake and coronary calcification. Coron Artery Dis 2005 16 199 203
24. Krueger T, Schlieper G, Schurgers L, Cornelis T, Cozzolino M, Jacobi J, Jadoul M, Ketteler M, Rump LC, Stenvinkel P, Westenfeld R, Wiecek A, Reinartz S, Hilgers RD, Floege J, Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol. Nephrol Dial Transplant 2014 29 1633 1638. doi: 10.1093/ndt/gft459
25. Stenflo J, Contributions of Gla and EGF-like domains to the function of vitamin K-dependent coagulation factors. Crit Rev Eukaryot Gene Expr 1999 9 59 88
26. Nakano T, Kawamoto K, Higashino K, Arita H, Prevention of growth arrest-induced cell death of vascular smooth muscle cells by a product of growth arrest-specific gene, gas6. FEBS Lett 1996 387 78 80
27. Fridell YW, Villa J Jr, Attar EC, Liu ET, GAS6 induces Axl-mediated chemotaxis of vascular smooth muscle cells. J Biol Chem 1998 273 7123 7126
28. Ishimoto Y, Ohashi K, Mizuno K, Nakano T, Promotion of the uptake of PS liposomes and apoptotic cells by a product of growth arrest-specific gene, gas6. J Biochem 2000 127 411 417
29. Li Y, Gerbod-Giannone MC, Seitz H, Cui D, Thorp E, Tall AR, Matsushima GK, Tabas I, Cholesterol-induced apoptotic macrophages elicit an inflammatory response in phagocytes, which is partially attenuated by the Mer receptor. J Biol Chem 2006 281 6707 6717. doi: 10.1074/jbc.M510579200
30. Avanzi GC, Gallicchio M, Bottarel F, GAS6 inhibits granulocyte adhesion to endothelial cells. Blood 1998 91 2334 2340
31. Clauser S, Meilhac O, Bièche I, Raynal P, Bruneval P, Michel JB, Borgel D, Increased secretion of Gas6 by smooth muscle cells in human atherosclerotic carotid plaques. Thromb Haemost 2012 107 140 149. doi: 10.1160/TH11-05-0368
32. Tjwa M, Bellido-Martin L, Lin Y, Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. Blood 2008 111 4096 4105. doi: 10.1182/blood-2007-05-089565
33. Angelillo-Scherrer A, de Frutos P, Aparicio C, Melis E, Savi P, Lupu F, Arnout J, Dewerchin M, Hoylaerts M, Herbert J, Collen D, Dahlbäck B, Carmeliet P, Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 2001 7 215 221. doi: 10.1038/84667
34. Nagata K, Ohashi K, Nakano T, Arita H, Zong C, Hanafusa H, Mizuno K, Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases. J Biol Chem 1996 271 30022 30027
35. Kruzynska-Frejtag A, Machnicki M, Rogers R, Markwald RR, Conway SJ, Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation. Mech Dev 2001 103 183 188
36. Oka T, Xu J, Kaiser RA, Melendez J, Hambleton M, Sargent MA, Lorts A, Brunskill EW, Dorn GW 2nd, Conway SJ, Aronow BJ, Robbins J, Molkentin JD, Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res 2007 101 313 321. doi: 10.1161/CIRCRESAHA.107.149047
37. Pohjolainen V, Rysä J, Näpänkangas J, Kööbi P, Eräranta A, Ilves M, Serpi R, Pörsti I, Ruskoaho H, Left ventricular periostin gene expression is associated with fibrogenesis in experimental renal insufficiency. Nephrol Dial Transplant 2012 27 115 122. doi: 10.1093/ndt/gfr279
38. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996 88 3698 3703
39. Smiles AM, Jenny NS, Tang Z, Arnold A, Cushman M, Tracy RP, No association of plasma prothrombin concentration or the G20210A mutation with incident cardiovascular disease: results from the Cardiovascular Health Study. Thromb Haemost 2002 87 614 621
40. Ohsaki Y, Shirakawa H, Miura A, Giriwono PE, Sato S, Ohashi A, Iribe M, Goto T, Komai M, Vitamin K suppresses the lipopolysaccharide-induced expression of inflammatory cytokines in cultured macrophage-like cells via the inhibition of the activation of nuclear factor κB through the repression of IKKα/β phosphorylation. J Nutr Biochem 2010 21 1120 1126. doi: 10.1016/j.jnutbio.2009.09.011
41. Ohsaki Y, Shirakawa H, Hiwatashi K, Furukawa Y, Mizutani T, Komai M, Vitamin K suppresses lipopolysaccharide-induced inflammation in the rat. Biosci Biotechnol Biochem 2006 70 926 932
42. Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, Hofman A, Witteman JC, Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 2004 134 3100 3105
43. Kaesler N, Magdeleyns E, Herfs M, Schettgen T, Brandenburg V, Fliser D, Vermeer C, Floege J, Schlieper G, Krüger T, Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation. Kidney Int 2014 86 286 293. doi: 10.1038/ki.2013.530
44. Doyon M, Mathieu P, Moreau P, Decreased expression of γ-carboxylase in diabetes-Associated arterial stiffness: impact on matrix Gla protein. Cardiovasc Res 2013 97 331 338. doi: 10.1093/cvr/cvs325
45. Holden RM, Morton AR, Garland JS, Pavlov A, Day AG, Booth SL, Vitamins K and D status in stages 3-5 chronic kidney disease. Clin J Am Soc Nephrol 2010 5 590 597. doi: 10.2215/CJN.06420909